| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Review Article |
From the Department of Pathology,* Leiden University Medical Center, Leiden; the Department of Pathology, University Medical Center St. Radboud, Nijmegen; and Pickcell Laboratories, Amsterdam, The Netherlands
Abstract
Cell adhesion receptors (CAMs) are actively involved in regulating various cell processes, including growth, differentiation, and cell death. Therefore, CAMs represent a large group of morphoregulating molecules, mediating cross-talk between cells and of cells with their environment. From this perspective, CAMs do contribute to cells and tissue organization, and in diseased tissue, to the disease development and biological characteristics. Therefore, observed changes in expression patterns of adhesion molecules may contribute to establish a diagnosis. A distinct shift in expression patterns in neoplastic epithelium has been described, for example for cadherins, integrins, and CD44. A relatively novel cell CAM, Ep-CAM, was first reported to be a pan-carcinoma antigen, although it is rather a marker of epithelial lineage. Several antibodies directed to Ep-CAM have been generated, and many epithelial tissues and their neoplastic appendages have been studied. This article outlines the results of these studies. Based on the results of these studies, we conclude that Ep-CAM immunohistochemistry can be a useful tool in the diagnosis of disturbed epithelial tissues.
This article has been cited by other articles:
 |
|
 |
|
  M. J. Hynes, K. M. Huang, and E. H. Huang Review Paper: Implications of the "Cancer Stem Cell" Hypothesis on Murine Models of Colon Cancer and Colitis-associated Cancer Veterinary Pathology, September 1, 2009; 46(5): 819 - 835. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ikeda, Y. Nakayama, Y. Hamada, M. Takeshita, H. Iwasaki, K. Maeshiro, Y. Yamashita, M. Kuroki, and S. Ikeda FU-MK-1 Expression in Human Gallbladder Carcinoma: An Antigenic Prediction Marker for a Better Postsurgical Prognosis Am J Clin Pathol, July 1, 2009; 132(1): 111 - 117. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. H. Huang, M. J. Hynes, T. Zhang, C. Ginestier, G. Dontu, H. Appelman, J. Z. Fields, M. S. Wicha, and B. M. Boman Aldehyde Dehydrogenase 1 Is a Marker for Normal and Malignant Human Colonic Stem Cells (SC) and Tracks SC Overpopulation during Colon Tumorigenesis Cancer Res., April 15, 2009; 69(8): 3382 - 3389. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Patriarca, P. Colombo, A. Pio Taronna, J. Wesseling, G. Franchi, F. Guddo, R. Naspro, R. M. Macchi, P. Giunta, M. Di Pasquale, et al. Cell Discohesion and Multifocality of Carcinoma In situ of the Bladder: New Insight From the Adhesion Molecule Profile (e-Cadherin, Ep-CAM, and MUC1) International Journal of Surgical Pathology, April 1, 2009; 17(2): 99 - 106. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Inada, A. Follenzi, K. Cheng, M. Surana, B. Joseph, D. Benten, S. Bandi, H. Qian, and S. Gupta Phenotype reversion in fetal human liver epithelial cells identifies the role of an intermediate meso-endodermal stage before hepatic maturation J. Cell Sci., April 1, 2008; 121(7): 1002 - 1013. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Brunner, M Prelog, I Verdorfer, A Tzankov, G Mikuz, and C Ensinger EpCAM is predominantly expressed in high grade and advanced stage urothelial carcinoma of the bladder J. Clin. Pathol., March 1, 2008; 61(3): 307 - 310. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Krishnakumar, A. Mohan, K. Mallikarjuna, N. Venkatesan, J. Biswas, M. P. Shanmugam, and L. Ren-Heidenreich EpCAM Expression in Retinoblastoma: A Novel Molecular Target for Therapy Invest. Ophthalmol. Vis. Sci., December 1, 2004; 45(12): 4247 - 4250. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
